Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Golding

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Medchemcomm|October 1, 2013
Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions†Electronic supplementary information (ESI) available: Experimental details for compound synthesis, analytical data for all compounds and intermediates. Details for the biological evaluation. Further details for the modeling. Table of combustion analysis data. See DOI: 10.1039/c3md00161jClick here for additional data fileTim J Blackburn, Shafiq Ahmed, Christopher R Coxon, et al.
Plos One|October 12, 2012
Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancerKelly Coffey, Timothy J Blackburn, Susan Cook, et al.
Organic & Biomolecular Chemistry|February 23, 2018
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approachDuncan C Miller, Mathew P Martin, Santosh Adhikari, et al.
Journal of Medicinal Chemistry|January 10, 2003
Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitorsDonald J Skalitzky, Joseph T Marakovits, Karen A Maegley, et al.
Oncotarget|November 12, 2016
Structure-guided design of purine-based probes for selective Nek2 inhibitionChristopher R Coxon, Christopher Wong, Richard Bayliss, et al.
Journal of Medicinal Chemistry|December 6, 2013
8-Substituted O(6)-cyclohexylmethylguanine CDK2 inhibitors: using structure-based inhibitor design to optimize an alternative binding modeBenoit Carbain, David J Paterson, Elizabeth Anscombe, et al.
RSC Medicinal Chemistry|January 22, 2021
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinaseChristopher J Matheson, Christopher R Coxon, Richard Bayliss, et al.
Journal of Medicinal Chemistry|July 17, 2013
1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activityCéline Cano, Kappusamy Saravanan, Chris Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2011
MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinonesAnna F Watson, Junfeng Liu, Karim Bennaceur, et al.
Chemistry & Biology|September 1, 2015
Identification and Characterization of an Irreversible Inhibitor of CDK2Elizabeth Anscombe, Elisa Meschini, Regina Mora-Vidal, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Medchemcomm|October 1, 2013
Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions†Electronic supplementary information (ESI) available: Experimental details for compound synthesis, analytical data for all compounds and intermediates. Details for the biological evaluation. Further details for the modeling. Table of combustion analysis data. See DOI: 10.1039/c3md00161jClick here for additional data fileTim J Blackburn, Shafiq Ahmed, Christopher R Coxon, et al.
Plos One|October 12, 2012
Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancerKelly Coffey, Timothy J Blackburn, Susan Cook, et al.
Organic & Biomolecular Chemistry|February 23, 2018
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approachDuncan C Miller, Mathew P Martin, Santosh Adhikari, et al.
Journal of Medicinal Chemistry|January 10, 2003
Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitorsDonald J Skalitzky, Joseph T Marakovits, Karen A Maegley, et al.
Oncotarget|November 12, 2016
Structure-guided design of purine-based probes for selective Nek2 inhibitionChristopher R Coxon, Christopher Wong, Richard Bayliss, et al.
Journal of Medicinal Chemistry|December 6, 2013
8-Substituted O(6)-cyclohexylmethylguanine CDK2 inhibitors: using structure-based inhibitor design to optimize an alternative binding modeBenoit Carbain, David J Paterson, Elizabeth Anscombe, et al.
RSC Medicinal Chemistry|January 22, 2021
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinaseChristopher J Matheson, Christopher R Coxon, Richard Bayliss, et al.
Journal of Medicinal Chemistry|July 17, 2013
1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activityCéline Cano, Kappusamy Saravanan, Chris Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2011
MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinonesAnna F Watson, Junfeng Liu, Karim Bennaceur, et al.
Chemistry & Biology|September 1, 2015
Identification and Characterization of an Irreversible Inhibitor of CDK2Elizabeth Anscombe, Elisa Meschini, Regina Mora-Vidal, et al.
Pageof 20